TrialThe New England journal of medicine2018
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
Alexander Drilon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1,417 papers cite itlatest 60 shown
this paperpooled ittrialcites it